Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PIRS save search
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech
Published: 2021-05-25 (Crawled : 13:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 21.62%
H: 68.44%
C: 67.11%
collaboration respiratory
Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment of Gastric Cancer
Published: 2021-06-24 (Crawled : 12:15) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 5.65%
H: 22.19%
C: 16.84%
treatment cancer drug designation
Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
Published: 2021-04-26 (Crawled : 13:15) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 0.0%
H: 6.8%
C: 6.14%
license gpt-3
Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference
Published: 2023-06-02 (Crawled : 22:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 0.0%
H: 5.88%
C: 5.35%
conference pharmaceuticals
Pieris Pharmaceuticals Announces $5 Million Milestone from Seagen for Initiation of Phase 1 Trial of CD228 x 4-1BB Bispecific Molecule (Mabcalin SGN-BB228 (PRS-346)
Published: 2023-01-10 (Crawled : 14:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 4.69%
H: 5.97%
C: 5.22%
cd228 pharmaceuticals trial milestone
Pieris Pharmaceuticals To Present at Jefferies Healthcare Conference
Published: 2022-06-02 (Crawled : 12:20) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: -3.87%
H: 8.62%
C: 5.17%
conference
Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member
Published: 2021-08-23 (Crawled : 00:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 0.0%
H: 7.43%
C: 6.93%
GH | News 4 | $18.1 4.38% 4.2% 1.6M
|
Health Services
|
| O: 1.19%
H: 5.11%
C: 4.88%
biopharma
Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference
Published: 2023-05-22 (Crawled : 14:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 1.34%
H: 4.59%
C: 4.59%
prs-400 conference presentation international pharmaceuticals preclinical
Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting
Published: 2023-04-17 (Crawled : 13:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 10.01%
H: 5.32%
C: 4.43%
prs-343 presentation positive pharmaceuticals meeting
HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors
Published: 2022-01-28 (Crawled : 13:30) - biospace.com/
ABT | News | $106.9 -0.64% 0.0% 5.1M
|
Health Technology
|
| O: 0.27%
H: 3.94%
C: 3.79%
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 0.61%
H: 3.66%
C: 3.05%
HTGM | $0.48 -20.0% -26.08% 0
|
Health Technology
|
| O: 4.76%
H: 3.57%
C: -9.09%
biopharma
Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
Published: 2023-05-10 (Crawled : 12:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: -1.76%
H: 4.19%
C: 2.99%
business pharmaceuticals financial results
Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
Published: 2023-08-17 (Crawled : 13:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 5.11%
H: 10.24%
C: 2.81%
bos-342 pharmaceuticals milestone study
Pieris Pharmaceuticals To Host Third Quarter 2022 Investor Call and Provide Corporate Update on November 2, 2022
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: -1.96%
H: 6.0%
C: 2.0%
pharmaceuticals update
Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team
Published: 2021-08-03 (Crawled : 13:00) - biospace.com/
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 1.42%
H: 2.38%
C: 1.96%
Pieris Pharmaceuticals Announces Presentation of Preclinical Data for Inhaled Jagged-1 Inhibitor PRS-400 at ERS
Published: 2022-08-24 (Crawled : 13:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 3.33%
H: 3.23%
C: 1.94%
prs-400 preclinical presentation
Pieris Pharmaceuticals Announces Successful Completion of Safety Milestone and Initiation of Efficacy Portion of Phase 2a Trial of PRS-060/AZD1402
Published: 2022-01-03 (Crawled : 12:30) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 1.59%
H: 3.52%
C: 1.82%
prs-060 phase 2 als trial milestone phase 2b
Pieris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: -0.55%
H: 3.59%
C: 0.83%
financial results results
Aerami Therapeutics Appoints Darlene Deptula-Hicks to its Board of Directors
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 2.87%
H: 0.0%
C: 0.0%
TTOO A | $2.76 1.47% 1.45% 320K
|
Health Technology
|
| O: -1.2%
H: 1.19%
C: -1.35%
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 0.0%
H: 3.59%
C: 0.77%
Pieris Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference
Published: 2021-05-20 (Crawled : 13:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 0.54%
H: 3.17%
C: 0.54%
conference
Pieris Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
PIRS | $11.88 1.64% 1.62% 40K
|
Health Technology
|
| O: 1.6%
H: 6.81%
C: 0.52%
financial results results
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.